Protalix Biotherapeutics, Inc.
PLX
Revenue
13.47M
▲9.73M▲259.50%
3 Months ChangeAssets
91.54M
▲1.72M▲1.91%
3 Months ChangeLiabilities
62.96M
▲2.92M▲4.86%
3 Months ChangeFree Cash Flow
3.59M
▲6.84M▲210.60%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0001558370-24-013664
2024-08-14
Form 10-Q
ID: 0001558370-24-012134
2024-08-14
Form 8-K
ID: 0001558370-24-012133
2024-06-28
Form 8-K
ID: 0001558370-24-009567
2024-05-10
Form 10-Q
ID: 0001558370-24-007695
2024-05-10
Form 8-K
ID: 0001558370-24-007692
2024-03-14
Form 8-K
ID: 0001558370-24-003160
2023-12-26
Form 8-K
ID: 0001558370-23-020006
2023-11-06
Form 10-Q
ID: 0001558370-23-017664
2023-11-06
Form 8-K
ID: 0001558370-23-017657